Table 2.
Group | Donor | Recipient | Treatment | Frequency of CAV | p-Value |
---|---|---|---|---|---|
1 | B10.BR | B6.RAG1−/− | αH-2Kk(IgG2a) | 5/5 | |
2 | αH-2Kk(IgG2a) + αNK1.1 | 2/5 | versus group 1 NS | ||
3 | F(ab’)2 fragment of αH-2Kk(IgG2a) ab + αNK1.1 | 0/5 | versus group 1 p < 0.01 | ||
4 | F(ab’)2 fragment of αH-2Kk(IgG2a) ab + αH-2Kk(IgG2a; 1 dose) | 0/3 | |||
5 | B6.RAG1−/− | B6.RAG1−/− | αH-2Kk(IgG2a) | 0/6 | versus group 1 p < 0.01 |